128
Views
22
CrossRef citations to date
0
Altmetric
Research Article

Elastic Liposomal Formulation for Sustained Delivery of Antimigraine Drug: In Vitro Characterization and Biological Evaluation

, , , &
Pages 1100-1110 | Published online: 20 Oct 2008

REFERENCES

  • D. K. Arulmozhi, A. Veeranjaneyulu, S. L. Bodhankar, and S. K. Arora. (2005). Effect of Sapindus trifoliatus on hyperalgesic in vivo migraine models, Brazil. J. Med. Biol. Research. 38:469–475.
  • M. E. Bigal, C. A. Bordini, A. L. Antoniazzi, and J. G. Speciali. (2003). The triptan formulations: A critical evaluation. Arq. Neuropsiquiatr. 61:313–320.
  • R. Cady. (2007). Pathophysiology of migraine. Pain Pract. 17:6–9.
  • G. Cevc, and e. G. Blum. (1992). Lipid vesicles penetrate into intact skin owing to transdermal owing to transdermal osmotic gradients and hydration force. Biochim. Biophys. Acta 1104:226–232.
  • G. Cevc, and A. G. Blume. (2002). New highly efficient formulation of diclofenac for the topical, transdermal administration in ultradeformable drug carriers, Transfersomes. Biochim. Biophys. Acta 1564:21–30.
  • G. Cevc, G. Blume, and A. Schatzlein. (1997). Transfersomes mediated transepidermal delivery improves the regiospecificity and biological activity of corticosteroids in vivo. J. Control. Release 45:211–226.
  • G. Cevc, G. Blume, A. Schatzlein, D. Gebauer, and A. Paul. (1996). The skin: A pathway for systemic treatment with patches and lipid based agent carriers. Adv. Drug Deliv. Rev. 18:349–378.
  • J. Chen, J. Xinguo, J. Wenming, M. Ni, G. Xiaoling, and Z. Qizhi. (2004). Liquid chromatographic method for the determination of rizatriptan in human plasma. J. Chromatogr. B 805:169–173.
  • M. J. Cumberbatch, R. G. Hill, and R. J. Hargreaves. (1997). Rizatriptan has central antinociceptive effects against durally evoked responses. Eur. J. Pharmacol 328:37–40.
  • N. Dayan, and E. Touitou. (2000). Carriers for skin delivery of trihexyphenidyl HCl: Ethosomes vs. liposomes. Biomaterials 21:1879–1885.
  • G. M. M. El Maghraby, A. C. Williams, and B. W. Barry. (2001). Skin delivery of 5-fluorouracil from ultradeformable and standard liposomes in vitro. J. Pharm. Pharmacol. 53:1069–1076.
  • J. Y. Fang, C. T. Hong, W. T. Chiu, and Y. Y. Wang. (2001). Effect of liposomes and niosomes on skin permeation of enoxacin. Int. J. Pharm 219:61–72.
  • A. Femenía-Font, C. Balaguer-Fernández, V. Merino, V. Rodilla, and A. López-Castellano. (2005). Effect of chemical enhancers on the in vitro percutaneous absorption of sumatriptan succinate. Eur. J. Pharm. Biopharm. 61:50–55.
  • A. Femenía-Font, C. Padula, F. Marra, C. Balaguer-Fernández, V. Merino, A. López-Castellano, S. Nicoli, and P. Santi. (2006). Bioadhesive monolayer film for the in vitro transdermal delivery of sumatriptan. J Pharm. Sci. 95:1561–1569.
  • N. Galeotti, C. Ghelardini, I. Grazioli, and C. Uslenghi. (2002). Indomethacin, caffeine and prochlorperazine alone and combined revert hyperalgesia in in-vivo models of migraine. Pharmacol. Res. 46:245–250.
  • C. Ghelardini, N. Galeotti, S. Donaldson, and A. Bartolini. (1998). The antimigraine drug ergotamine is endowed with antihyperalgesic activity. Phytother. Res. 12:S10–S12.
  • C. Hofer, R. Hartung, R. Gobel, P. Deering, A. Lehmer, and J. Breul. (2000). New ultra deformable drug carriers for potential transdermal application of interleukin-2 and interferon-alpha: Theoretical and practical aspects. World J. Surg. 24:1187–1189.
  • P. L. Honeywell-Nguyen, P. M. Frederik, P. H. H. Bomans, H. E. Junginger, and J. A. Bouwstra. (2002). Transdermal delivery of pergolide from surfactant-based elastic and rigid vesicles: Characterization and in vitro transport studies. Pharm. Res. 19:992–998.
  • S. Jain, N. Jain, D. Bhadra, A. K. Tiwary, and N. K. Jain. (2005). Transdermal delivery of an analgesic agent using elastic liposomes: Preparation characterization and performance evaluation. Curr. Drug Deliv. 2 (3):223–233.
  • S. Jain, P. Jain, R. B. Umamaheshwari, and N. K. Jain. (2003). Transfersomes—a novel vesicular carrier for effective transdermal delivery, preparation development and characterization. Drug Dev. Ind. Pharm. 29 (9):1013–1026.
  • S. Jain, A. K. Tiwary, and N. K. Jain. (2006). Sustained and targeted delivery of an anti-HIV agent using elastic lipsomal formulation: Mechanism of action. Curr. Drug Deliv. 3 (2):157–166.
  • D. Lichtenberg, R. J. Robson, and E. A. Dennis. (1983). Solublization of phospholipids by detergents: Structural and kinetic aspects. Biochim. Biophys. Acta 737:285–304.
  • V. Limmroth, A. J. Dowson, H. C. Diener, and C. Dahlof. (2004). Non-oral delivery systems in headache therapy: Focus on intranasal delivery. Am. J. Drug Deliv. 2 (1):59–68.
  • R. B. Lipton, J. Pascual, and P. J. Goadsby. (2001). Effect of rizatriptan and other triptans on the nausea symptom of migraine: A post hoc analysis. Headache 41:754–763.
  • T. Liu, R. Guo, W. Hua, and u. J. Qi. (2007). Structure behaviors of hemoglobin in PEG 6000/Tween 80/Span 80/H2O niosome system. Colloids Interfaces A: Physicochem. Eng. Aspects 293:255–261.
  • W. Pathirana, S. H. Kariyaswasam, and H. Tibbotumununuwa. (2006). Brain targeted transcranial route of drug delivery of diazepam. Ind. J. Pharm. Sci. 68 (4):493–500.
  • A. D. Ronald, (2004). Transdermal migraine therapy EU Patent EP1435945.
  • E. Touitou, N. Dayan, L. Bergelson, B. Godin, and M. Eliaz. (2000). Ethosomes—novel vesicular carriers for enhanced delivery: Characterization and skin penetration properties. J. Control. Release 65:403–418.
  • M. Trotta, E. Peira, M. E. Carlotti, and M. Gallarate. (2004). Deformable liposomes for dermal administration of methotrexate. Int. J. Pharm. 270:119–125.
  • M. Trotta, E. Peira, F. Debernardi, and M. Gallarate. (2002). Elastic liposomes for skin delivery of dipotassium glycyrrhizinate. Int. J. Pharm. 241:319–327.
  • B. A. I. vanden Bergh, P. W. Wertz, H. E. Junginger, and J. A. Bouwstra. (2001). Elasticity of vesicle assessed by electron spin resonance, electron microscopy, and extrusion measurement. Int. J. Pharm. 217:13–24.
  • C. M. Villalon, D. Centurión, L. F. Valdivia, P. Vriesl, and P. R. Saxena. (2003). Migraine: Pathophysiology, pharmacology, treatment and future trends. Curr. Vasc. Pharmacol. 1:71–84.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.